[HTML][HTML] First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19
…, A Vanni, M Capone, G Lamacchia… - The Journal of …, 2021 - Am Soc Clin Investig
The characterization of the adaptive immune response to COVID-19 vaccination in individuals
who recovered from SARS-CoV-2 infection may define current and future clinical practice. …
who recovered from SARS-CoV-2 infection may define current and future clinical practice. …
[HTML][HTML] Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
Background and Purpose Waning immunity and the surge of SARS-CoV-2 variants are
responsible for breakthrough infections, ie, infections in fully vaccinated individuals. Although the …
responsible for breakthrough infections, ie, infections in fully vaccinated individuals. Although the …
[HTML][HTML] SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies
…, A Vanni, M Spinicci, G Lamacchia… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Immunization against SARS-CoV-2, the causative agent of COVID-19, occurs
via natural infection or vaccination. However, it is currently unknown how long infection- or …
via natural infection or vaccination. However, it is currently unknown how long infection- or …
[HTML][HTML] SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including omicron
…, A Vanni, M Spinicci, M Capone, G Lamacchia… - Frontiers in …, 2022 - frontiersin.org
Although accumulating data have investigated the effect of SARS-CoV-2 mutations on antibody
neutralizing activity, less is known about T cell immunity. In this work, we found that the …
neutralizing activity, less is known about T cell immunity. In this work, we found that the …
[HTML][HTML] Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma–affected patients
Background Patients with B-cell lymphoma are a fragile category of subjects, particularly
exposed to infections and characterized by an impaired vaccination response due to the …
exposed to infections and characterized by an impaired vaccination response due to the …
[HTML][HTML] Fourth dose of mRNA COVID-19 vaccine transiently reactivates spike-specific immunological memory in people living with HIV (PLWH)
Background: People Living With HIV (PLWH), with advanced disease, lower CD4+ T cell
counts or an unsuppressed HIV viral load can have a suboptimal vaccine response. For this …
counts or an unsuppressed HIV viral load can have a suboptimal vaccine response. For this …
Clonally expanded PD‐1‐expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients
…, P Maschmeyer, G Lamacchia… - European journal of …, 2023 - Wiley Online Library
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic condition in childhood.
The disease etiology remains largely unknown; however, a key role in JIA pathogenesis …
The disease etiology remains largely unknown; however, a key role in JIA pathogenesis …
First dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in ex COVID-19 subjects
Characterizing the adaptive immune response to COVID-19 vaccination in individuals who
recovered from SARS-CoV-2 infection may define current and future clinical practice. To …
recovered from SARS-CoV-2 infection may define current and future clinical practice. To …
Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
Immunization against SARS-CoV-2, the causative agent of coronavirus disease-19 (COVID-19)
occurs via natural infection or vaccination. However, it is currently unknown how long …
occurs via natural infection or vaccination. However, it is currently unknown how long …
[PDF][PDF] Study of biochemical mechanisms induced by Gluten Friendly TM in vitro and in vivo on coeliac patients
M Daniela, C Lamacchia - fair.unifg.it
This thesis aimed to investigate the biochemical mechanisms induced by “Gluten FriendlyTM”
in vitro and in vivo on coeliac patients. “Gluten Friendly™” is a patented technology (Italian …
in vitro and in vivo on coeliac patients. “Gluten Friendly™” is a patented technology (Italian …
